In the article titled “Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting IκBα/NFκB and enhancing Nrf2/HO-1” [1], an error was identified in Figure 8(b) where the same original blots were mistakenly used for T-Nrf2 and HO-1 when preparing the image. The authors have provided the correct images for T-Nrf2 and HO-1 and the revised Figure 8 is as below: